Breaking News

COVID-19 Update: FDA Scales Back Domestic Inspections

Temporarily postpones all domestic routine surveillance facility inspections, for-cause inspections will be evaluated and will proceed if mission-critical.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

In keeping with the White House Coronavirus Task Force and cross-government guidance, this week FDA directed all eligible employees to begin teleworking. This does not apply to those carrying out non-portable activities, such as certain lab activities or the monitoring of imported products. The FDA continues to adjust its approach to a number of activities, including facility inspections for all FDA-regulated products. Earlier this month, the FDA said it was postponing most foreign facility i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters